title: Protective role of mouse MBL-C on intestinal mucosa during Shigella flexneri invasion.
abstract: Mannan-binding lectin (MBL) is a C-type serum lectin, which is believed to play an important role in the innate immunity against a variety of pathogens. MBL can bind to sugar determinants of a wide variety of microorganisms, neutralize them and inhibit infection by complement activation through the lectin pathway and opsonization by collectin receptors. Given that small intestine is a predominant site of extrahepatic expression of MBL, here we addressed the question whether MBL is involved in mucosal innate immunity. The carbohydrate recognition domain (CRD) genes of mouse MBL-C (mMBL-C) were cloned and expressed in Escherichia coli. Recombinant mMBL-C-CRD binds to Shigella flexneri 2a in a calcium-dependent manner and that interaction could be blocked by the anti-mMBL-C-CRD antibody. mMBL-C-CRD protein could inhibit the adhesion of S. flexneri 2a to intestinal mucosa, while administration of anti-mMBL-C-CRD antibody caused an increased level of bacteria adhesion in vitro. Administration of recombinant mMBL-C-CRD protein reduced the secretion of IL-6 and monocyte chemoattractant protein 1 from primary intestinal epithelial cells stimulated with S. flexneri 2a. Furthermore, neutralization of MBL activity by anti-MBL-C-CRD resulted in a significant increase in the number of S. flexneri 2a that colonized the intestines of BALB/c mice and attenuated the severity of inflammation seen in the areas of bacterial invasion. These findings suggest that mMBL-C may protect host intestinal mucosa by directly binding to the bacteria.
authors.affiliation: Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
authors.forename: Da-Ming
authors.initials: DM
authors.lastname: Zuo
authors.forename: Li-Yun
authors.initials: LY
authors.lastname: Zhang
authors.forename: Xiao
authors.initials: X
authors.lastname: Lu
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Zheng-Liang
authors.initials: ZL
authors.lastname: Chen
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D018932:Chemokine CCL2 / Q000276:immunology / Q000378:metabolism; D004405:Dysentery, Bacillary / Q000276:immunology*; D007113:Immunity, Innate; D015850:Interleukin-6 / Q000276:immunology / Q000378:metabolism; D007413:Intestinal Mucosa / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D007421:Intestine, Small / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D037601:Mannose-Binding Lectin / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D012763:Shigella flexneri / Q000276:immunology* / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism
chemical_list: D000906:Antibodies; D018932:Chemokine CCL2; D015850:Interleukin-6; D037601:Mannose-Binding Lectin; D014409:Tumor Necrosis Factor-alpha
references.citation: Bull World Health Organ. 1999;77(8):651-66
references.pmid: 10516787
references.citation: Clin Exp Immunol. 2003 Nov;134(2):217-24
references.pmid: 14616780
references.citation: Nature. 1992 Nov 12;360(6400):127-34
references.pmid: 1436090
references.citation: Trends Microbiol. 1998 Jul;6(7):282-7
references.pmid: 9717217
references.citation: Mol Immunol. 2005 Feb;42(2):145-52
references.pmid: 15488604
references.citation: Int J Med Microbiol. 2003 Apr;293(1):55-67
references.pmid: 12755366
references.citation: J Infect Dis. 2005 May 15;191(10):1697-704
references.pmid: 15838797
references.citation: Vet Res. 2006 May-Jun;37(3):359-68
references.pmid: 16611553
references.citation: Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S314-8
references.pmid: 2047656
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2396-401
references.pmid: 17287349
references.citation: Glycobiology. 1996 Jul;6(5):543-50
references.pmid: 8877375
references.citation: Immunology. 1999 Jul;97(3):385-92
references.pmid: 10447758
references.citation: Eur J Clin Invest. 2005 Aug;35(8):531-4
references.pmid: 16101674
references.citation: Mamm Genome. 1995 Feb;6(2):103-10
references.pmid: 7766991
references.citation: Lancet. 2002 May 4;359(9317):1569-73
references.pmid: 12047967
references.citation: Eur J Biochem. 2004 Apr;271(7):1229-49
references.pmid: 15030473
references.citation: Infect Immun. 1995 Jul;63(7):2537-40
references.pmid: 7540596
references.citation: Trends Parasitol. 2003 Jul;19(7):305-11
references.pmid: 12855381
references.citation: Can J Gastroenterol. 2002 Apr;16(4):241-6
references.pmid: 11981577
references.citation: Science. 1999 May 21;284(5418):1313-8
references.pmid: 10334979
references.citation: J Exp Med. 1989 Jan 1;169(1):185-96
references.pmid: 2909656
references.citation: J Immunol. 2000 Mar 1;164(5):2610-8
references.pmid: 10679100
references.citation: Tissue Antigens. 2006 Sep;68(3):193-209
references.pmid: 16948640
references.citation: Appl Microbiol. 1970 May;19(5):776-80
references.pmid: 5422307
references.citation: Hepatology. 2005 Nov;42(5):1037-45
references.pmid: 16231358
references.citation: Annu Rev Immunol. 2003;21:547-78
references.pmid: 12524383
references.citation: Immunol Today. 1994 Feb;15(2):67-74
references.pmid: 8155265
references.citation: J Exp Med. 1956 Sep 1;104(3):411-8
references.pmid: 13357693
references.citation: J Exp Med. 2004 May 17;199(10):1379-90
references.pmid: 15148336
references.citation: J Virol. 2000 Jun;74(12):5597-603
references.pmid: 10823867
references.citation: Lancet. 1999 Mar 27;353(9158):1049-53
references.pmid: 10199352
references.citation: Infect Immun. 2000 Jun;68(6):3172-9
references.pmid: 10816460
references.citation: J Immunol. 2006 Feb 1;176(3):1769-75
references.pmid: 16424207
references.citation: J Immunol. 2002 Dec 15;169(12):6945-50
references.pmid: 12471128
references.citation: Infect Immun. 2000 Feb;68(2):688-93
references.pmid: 10639434
references.citation: Curr Opin Immunol. 2006 Feb;18(1):16-23
references.pmid: 16368230